Sacral nerve stimulation (SNS) for faecal incontinence (FI) is recommended by NICE as a cost-effective use of healthcare resources compared with alternative treatments for faecal incontinence. The technology was not available to be implanted in patients in Wales prior to 2018. However, in 2018, Health Technology Wales (HTW) concluded “NHS Wales should adopt this guidance or justify why it has not been followed”. It is estimated that over 150 patients per year in Wales could benefit from this device to treat FI and more if extended to urinary incontinence (UI). After proof of concept operations in Cardiff and Vale and thanks to the expertise and support from a lead colorectal surgeon and Head of Procurement at Cardiff and Vale, a risk share partnership has been entered into with the supplier where the SNS device is paid for after 12 months provided the patient attains a specified reduction in incontinence episodes and a measured increase in QoL.
To find out more about value-based healthcare and the opportunity for the industry in Wales, visit the Life Sciences Hub Wales website. https://lshubwales.com/our-priorities/value-based-healthcare
James Griffiths, Value Based Procurement Project Manager, NWSSP